GeoVax Labs Inc (GOVX)

[remind2]

GOVX: Immune to pumping.


GeoVax has an HIV prevention vax in Phase Two trials & the stock is .06 cents with a $3.2M market cap.

Today, the Feds fully funded the GOVX trials AND is giving them huge support via free National Lab access, which likely amounts to more than the actual monetary award.

In addition, GOVX has another major grant in the pipeline from the Feds for Zika, payable at any time.

Investors here are not going to make their money off the backs of other retail investors via a penny or two pump.

Investors will get the serious dough from Sanofi or Gilead via a buyout that could easily be north of $150M. A 25 bagger for todays buyers.

Makes no difference if anyone on this board buys or sells at this point.

The NIH is the only DD that matters and they just upped their investment in GOVX.


Link:
https://www.geovax.com/component/easyblog/entry/2017/04/03/geovax-awarded-658-000-nih-grant-for-its-hiv-vaccine-program.html?Itemid=101